The Challenging world of cytopenias: Distinguishing myelodysplastic syndromes from other disorders of marrow failure

Amy E. DeZern, Mikkael A. Sekeres

Research output: Contribution to journalReview articlepeer-review

Abstract

Over the past decade, our understanding of bone marrow failure has advanced considerably. Marrow failure encompasses multiple overlapping diseases, and there is increasing availability of diagnostic tools to distinguish among the subtypes. Identification of genetic alterations that underlie marrow failure has also greatly expanded, especially for myelodysplastic syndromes. Molecular markers are increasingly used to guide the management of myelodysplasia and may distinguish this diagnosis from other marrow failure disorders. This review summarizes the current state of distinguishing among causes of marrow failure and discusses the potential uses of multiple diagnostic and prognostic indicators in the management of myelodysplastic syndromes and other bone marrow failure disorders.

Original languageEnglish (US)
Pages (from-to)735-745
Number of pages11
JournalOncologist
Volume19
Issue number7
DOIs
StatePublished - 2014

Keywords

  • Aplastic anemia
  • Bone marrow failure
  • Large granular leukemia
  • Molecularmarkers
  • Myelodysplastic syndrome
  • PNH
  • SNP array

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The Challenging world of cytopenias: Distinguishing myelodysplastic syndromes from other disorders of marrow failure'. Together they form a unique fingerprint.

Cite this